1. Home
  2. MNKD vs TDOC Comparison

MNKD vs TDOC Comparison

Compare MNKD & TDOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • TDOC
  • Stock Information
  • Founded
  • MNKD 1991
  • TDOC 2002
  • Country
  • MNKD United States
  • TDOC United States
  • Employees
  • MNKD N/A
  • TDOC N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • TDOC Medical/Nursing Services
  • Sector
  • MNKD Health Care
  • TDOC Health Care
  • Exchange
  • MNKD Nasdaq
  • TDOC Nasdaq
  • Market Cap
  • MNKD 1.4B
  • TDOC 1.2B
  • IPO Year
  • MNKD 2004
  • TDOC 2015
  • Fundamental
  • Price
  • MNKD $4.15
  • TDOC $6.93
  • Analyst Decision
  • MNKD Strong Buy
  • TDOC Buy
  • Analyst Count
  • MNKD 5
  • TDOC 19
  • Target Price
  • MNKD $9.40
  • TDOC $9.60
  • AVG Volume (30 Days)
  • MNKD 1.9M
  • TDOC 4.9M
  • Earning Date
  • MNKD 05-08-2025
  • TDOC 04-30-2025
  • Dividend Yield
  • MNKD N/A
  • TDOC N/A
  • EPS Growth
  • MNKD 228.27
  • TDOC N/A
  • EPS
  • MNKD 0.10
  • TDOC N/A
  • Revenue
  • MNKD $297,595,000.00
  • TDOC $2,552,812,000.00
  • Revenue This Year
  • MNKD $14.36
  • TDOC N/A
  • Revenue Next Year
  • MNKD $13.36
  • TDOC $1.32
  • P/E Ratio
  • MNKD $40.01
  • TDOC N/A
  • Revenue Growth
  • MNKD 32.50
  • TDOC N/A
  • 52 Week Low
  • MNKD $4.05
  • TDOC $6.35
  • 52 Week High
  • MNKD $7.63
  • TDOC $15.21
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 37.04
  • TDOC 43.64
  • Support Level
  • MNKD $4.07
  • TDOC $6.89
  • Resistance Level
  • MNKD $4.25
  • TDOC $7.34
  • Average True Range (ATR)
  • MNKD 0.16
  • TDOC 0.27
  • MACD
  • MNKD -0.03
  • TDOC 0.00
  • Stochastic Oscillator
  • MNKD 12.82
  • TDOC 22.55

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About TDOC Teladoc Health Inc.

Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with Better convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.

Share on Social Networks: